Bryan Marra's practice focuses on counseling clients in government merger reviews and investigations of alleged anti-competitive conduct, as well as in antitrust litigation. He has represented clients in Department of Justice and FTC merger investigations in a wide range of industries, including media, telecommunications, consumer products, and the hospital sector.  

In addition, Mr. Marra has significant experience in pharmaceutical antitrust matters, representing clients in government investigations involving Hatch-Waxman patent settlements and lifecycle management practices. He has led the response to a number of complex investigations and has particular expertise in managing the e-discovery process, including use of technology-assisted review and other techniques to efficiently manage and streamline the compliance process. Before joining Arnold & Porter, Mr. Marra also served as a Legal Fellow on the Senate Judiciary Committee, Antitrust Subcommittee.


  • Multiple pharmaceutical companies in responding to FTC and state attorneys general investigations involving whether settlement of Hatch-Waxman patent litigation and/or company lifecycle management practices illegally delayed generic drug competition.
  • Global pharmaceutical company in defense of antitrust class actions alleging sham litigation based on Hatch-Waxman patent infringement suits; defeated indirect purchaser class certification.
  • Auto parts maker in FTC investigation of an agreement not to compete related to a joint venture; the investigation was closed without action.


  • JD, Georgetown University Law Center, 2002, magna cum laude
  • BA, University of Wisconsin, 1998, with honors
  • District of Columbia

Email Disclaimer